scholarly journals Performance Analysis of Pulmonary Tuberculosis Treatment in Indonesia

2021 ◽  
Author(s):  
Chandramouli M.T

AbstractLife-threatening adverse reactions of antitubercular drugs are uncommon; however, thrombocytopenia is one such rare complication encountered with rifampicin, isoniazid, ethambutol, and pyrazinamide. Rifampicin is the most effective drug and its use in the tuberculosis treatment led to the emergence of modern and effective short-course regimens. I am reporting case series of three patients with pulmonary tuberculosis presented with rifampicin-induced thrombocytopenia.


PLoS ONE ◽  
2018 ◽  
Vol 13 (11) ◽  
pp. e0207404
Author(s):  
Gokul Raj Kathamuthu ◽  
Kadar Moideen ◽  
Vaithilingam V. Banurekha ◽  
Dina Nair ◽  
R. Sridhar ◽  
...  

Author(s):  
P. G. Gadzhieva ◽  
D. B. Giller ◽  
A. A. Glotov ◽  
O. Sh. Kesaev ◽  
V. V. Koroev ◽  
...  

Objective. To increase efficiency of cavitary pulmonary tuberculosis treatment by developing modern indications and technology of extrapleural pneumolysis with filling material.Material and methods. We reviewed 25 patients with cavitary pulmonary tuberculosis and bacterial excretion who had undergone extrapleural pneumolysis with different types of filling material in 2004–2015. In 16 cases, we performed surgery in patients with one lung.Results. 56% of operated patients demonstrated extensively drug-resistant TB, 40% had multidrug-resistant TB. Cavities were closed and bacterial excretion ceased in 92% of patients at discharge. Long-term results with observation period from 1 to 12 years were analyzed in 24 patients, 17 (71%) of them had complete clinical efficacy.Conclusion. Extrapleural pneumolysis is a mini-invasive surgical treatment that can prove positive effect in patients with non-fibrotic changes in a cavity wall and pathological process in upper parts of the lungs. 


2021 ◽  
Vol 6 (2) ◽  
pp. 62-64
Author(s):  
Masdiwani Noviana Simanjuntak ◽  
Ade Pryta Simaremare ◽  
Rosminta Girsang

Background : Pulmonary tuberculosis is an infectious disease caused by mycobacterium tuberculosis. This bactery can be transmitted through airbone particles and droplets. The treatment is a long term therapy and can be a stressor which effect patient’s physical and psychologycal, that leads to depression. Objective : The objective of this study was to determine the correlation between pulmonary tuberculosis treatment duration and depression score.  Methods : This study was a correlative analysis with cross sectional design. The sample were 52 respondents whom currently endured the treatment of pulmonary tuberculosis in pulmonary unit in RSUD Pirngadi Medan, selected by consecutive sampling. Beck’s inventory depression II questionnaires were used to measure depression score. The data were analyzed with pearson correlation test.  Result : There was a low negative correlation between duration of pulmonary tuberculosis treatment and depression score (p = 0,027 ; r = -0,309) Conclusion  : The longer duration of pulmonary tuberculosis treatment, the lower the depression score. 


2013 ◽  
Vol 4 ◽  
Author(s):  
Peresi Eliana ◽  
Oliveira Larissa ◽  
Da Silva Weber ◽  
Da Costa Erica ◽  
Araujo Junior Jo�o ◽  
...  

2021 ◽  
Vol 5 (01) ◽  
pp. 29-32
Author(s):  
Joko Sapto Pramono ◽  
Nilam Noorma ◽  
Andi Lis Arming Gandini ◽  
Sopia Fitriani

Pulmonary tuberculosis treatment causes various side effects including nausea and vomiting, itching, vision problems, and anemia. Drug side effects in the early stages are one of the causes of non-adherence to complete treatment. The purpose of this study was to analyze the effect of the side effects Tuberculosis treatment in the early stages on treatment compliance for tuberculosis patients. This study used a cross sectional design. Samples were taken as many as 71 respondents, the instruments used were side effects of early-stage tuberculosis treatment and compliance with tuberculosis treatment in tuberculosis patients from the Morisky Medication Adherence Scale (MMAS). The results of the study found 97.7% adherent and 2.3% non-adherent, 39.5% mild side effects and 60.5% severe side effects. Chi-square test showed that no significant difference between the side effects of TB treatment in the early stages of tuberculosis treatment compliance in patients p = 0.669 at significant level of 95% (α = 0.05). There was no effect between the side effects of Tuberculosis treatment in the early stages of treatment compliance for Tuberculosis patients. It was recommended that health workers continue to monitor the side effects of tuberculosis treatment and provide motivation to carry out treatment completely. Keywords: side effects; early stage; treatment; pulmonary tuberculosis; compliance


2017 ◽  
Vol 42 (3) ◽  
pp. 337-344 ◽  
Author(s):  
P. Tanvejsilp ◽  
E. Pullenayegum ◽  
M. Loeb ◽  
J. Dushoff ◽  
F. Xie

2021 ◽  
Vol 11 (1) ◽  
pp. 51
Author(s):  
Suarnianti Suarnianti ◽  
Chairul Hasan Selan ◽  
Susi Sastika Sumi

Tuberculosis (TB) is an infectious disease which is the leading cause of ill health, one of the top 10 causes of death worldwide and the leading cause of death from a single infectious agent (ranking above HIV / AIDS). WHO estimates that there are 23,000 cases of MDR / RR in Indonesia. In 2017 there were 442,000 TB cases recorded in the program, of which an estimated 8,600-15,000 MDR / RR TB, (estimated 2.4% of new cases and 13% of previously treated TB patients), but only 27.36% treated. The aim of this literature is to evaluate peer group support and family support on treatment adherence to pulmonary tuberculosis patients. This study used a systematic literature review design. Articles were collected through the PubMed and Google Scholar databases published from 2016-2020 using the keywords peer group support, family support, medication adherence, pulmonary tuberculosis. The results of the literature review showed that providing peer group support or family support can have an impact positive for pulmonary tuberculosis patients. The conclusion in this study is that patients who get support from either peer group support or family support can significantly improve compliance with pulmonary tuberculosis treatment so that it can increase the success rate of pulmonary tuberculosis treatment. Keywords: peer group support; family support; treatment compliance; pulmonary tuberculosis ABSTRAK Tuberkulosis (TB) adalah penyakit menular yang merupakan penyebab utama masalah kesehatan yang buruk, salah satu dari 10 penyebab utama kematian di seluruh dunia dan penyebab utama kematian dari satu agen infeksi tunggal (peringkat di atas HIV / AIDS). WHO memperkirakan ada 23.000 kasus MDR/RR di Indonesia. Pada tahun 2017 kasus TB yang tercatat di program ada sejumlah 442.000 kasus yang mana dari kasus tersebut diperkirakan ada 8.600-15.000 MDR/RR TB, (perkiraan 2,4% dari kasus baru dan 13% dari pasien TB yang diobati sebelumnya), tetapi cakupan yang diobati baru sekitar 27,36%. Tujuan Literatur ini untuk mengevaluasi peer group support dan family support terhadap kepatuhan pengobatan pasien tuberkulosis paru. Penelitian ini menggunakan desain systematic literature review. Artikel dikumpulkan melalui database PubMed dan Google Scholar yang dipublikasikan dari tahun 2016-2020 dengan menggunakan kata kunci peer group support, family support, kepatuhan pengobatan, tuberkulosis paru. Hasil literature review menunjukkan bahwa pemberian peer group support atau family support dapat memberikan dampak yang positif kepada pasien tuberkulosis paru. Kesimpulan dalam penelitian ini bahwa pasien yang mendapatkan dukungan baik peer group support atau family support secara signifikan dapat meningkatkan kepatuhan pengobatan tuberkulosis paru sehingga dapat meningkatkan tingkat keberhasilan pengobatan tuberkulosis paru Kata kunci: peer group support; family support; kepatuhan pengobatan; tuberkulosis paru


Sign in / Sign up

Export Citation Format

Share Document